Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis

Trial Profile

Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis

Recruiting
Phase of Trial: Phase III

Latest Information Update: 28 Jun 2017

At a glance

  • Drugs Triamcinolone (Primary)
  • Indications Anterior uveitis; Intermediate uveitis; Panuveitis; Posterior uveitis
  • Focus Adverse reactions; Registrational
  • Acronyms AZALEA
  • Sponsors Clearside Biomedical
  • Most Recent Events

    • 22 May 2017 Status changed from not yet recruiting to recruiting.
    • 03 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top